Observations placeholder
Benicar
Identifier
018033
Type of Spiritual Experience
Number of hallucinations: 72
Background
A description of the experience
Olmesartan medoxomil is an angiotensin II receptor antagonist which has been used for the treatment of high blood pressure. It was developed in 1995, and is sold under the trade name Benicar Olmecip(Cipla)Olsar . An ester prodrug, it is completely and rapidly hydrolyzed to the active acid form, olmesartan .
Olmesartan is indicated for the treatment of hypertension. Contraindications for treatment with olmesartan include biliary obstruction. Another major contraindication is pregnancy; reports in the scientific literature reveal fetal malformations for pregnant women taking sartan-derived drugs
On Jan, 02, 2017 18,291 people reported to have side effects when taking Benicar.
Among them, 72 people (0.39%) have Hallucinations
On Sep, 21, 2015: 12,915 people reported to have side effects when taking Benicar. Among them, 152 people (1.18%) have Death.